Classification

Note
Metanephric adenoma belongs to the category of Metanephric tumor in the WHO histological classification of tumors of the kidney.
Clinics and pathology
Epidemiology
Metanephric adenomas are uncommon but occur across a wide range of patients, from infants to elder individual. The peak age frequency is 40 to 69 years. There is a female predominance (2.3:1). Ten percent of patients present with polycythemia.
Clinics
Mostly are incidentally discovered. Some patients present with hematuria and abdominal or flank pain.
Pathology
Grossly, the tumors are solid, gray to tan in color, and homogenous on cut surface. Most tumors are well-demarcated but lack a capsule. Microscopically, the tumor is chiefly composed of tightly packed primitive tubules and acina, with frequent papillary or glomeruloid structures. 
Treatment
Surgical excision.
Prognosis
The vast majority of metanephric adenomas behave in a benign fashion. Cases of regional lymph node metastasis and sarcomatoid changes have been individually reported.
Cytogenetics
Note
Karyotyping of a total of five cases revealed negative findings, with the exception of a dual balanced translocation of t(1;22)(q22;13) and t(15;16)(q21;p13) in one case. Sporadic allelic imbalances involving chromosomes 2p, 7, 8p, 12q, 16q, and 20q were identified in 18-56% of cases. A deletion in chromosome 2p was described, and a tumor suppressor gene region on 2p13 was delineated. One study of array comparative genomic hybridization (aCGH) reported no copy number changes in six cases, while another study of a CGH on 9 cases showed normal chromosome copy number in 4, sporadic chromosomal imbalances in 3, and multiple chromosomal gains and losses in 2.
